 |
市場調查報告書
商品編碼
2051150
藥局市場：按產品類型、治療領域、應用和地區分類Compounding Pharmacies Market, By Product Type, By Therapeutic Area, By Application, By Geography |
||||||
價格
簡介目錄
預計到2026年，藥局市場規模將達到126.6億美元，到2033年將達到196.8億美元。預計從2026年到2033年，其複合年成長率將達到6.5%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 126.6億美元 |
| 歷史數據時期： | 2020-2024 | 預測期： | 2026-2033 |
| 2026年至2033年預測期間的複合年成長率： | 6.50% | 2033 年預計值： | 196.8億美元 |
受複雜疾病個人化用藥需求不斷成長的推動，全球藥局市場預計在預測期內將顯著成長。當FDA核准的食品藥物管理局藥缺貨時，藥局會透過組合和調整成分來定製配方，以滿足患者的特定臨床需求。這使得某些特定配方成為可能，例如滿足精確劑量要求的配方，或適用於無法吞嚥固態片劑的兒童和老年患者的配方。此外，藥房能夠生產具有獨特口味和給藥途徑的藥物，從而擴展了治療選擇。慢性病患者數量的成長也推動了處方藥需求的增加。
市場動態
由於全球範圍內慢性病盛行率不斷上升，需要客製化藥物治療，全球藥局市場正經歷強勁成長。此外，老年人口的成長也推動了市場成長，老年人需要特殊的配方和劑型。與非處方藥（OTC）相比，藥局具有許多優勢，例如獨特的劑型、兒童配方以及滿足個別患者需求的能力，這些優勢也可能促進市場成長。然而，處方藥嚴格的法規結構和品質標準可能會阻礙市場成長。價格昂貴的非處方藥替代品也可能成為限制因素。新興市場醫療保健支出的成長以及配藥過程中先進技術的應用，可能為市場成長帶來可觀的機會。
本次調查的主要特點
- 本研究確定了各細分市場的潛在收入成長機會，並說明了該市場具有吸引力的投資提案矩陣。
- 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
- 本研究根據公司亮點、產品系列、主要特點、財務表現和策略等參數，對全球藥房市場的主要參與者進行了分析。
- 本研究涵蓋的主要公司包括 Avella Specialty Pharmacy、Central Admixture Pharmacy Services、Fagron、Fresenius Kabi AG、PharMEDium Services、Institutional Pharmacy Solutions、Cantrell Drug Company、Triangle Compounding Pharmacies、Lorraine's Pharmacy、Rx3 Compounding Pharmacyn、Bounding Pharmacies、Lorraine's Pharmaini、Rx3 Compounding Pharmacys、Bounding Pharmacies、Bound、Clini Pharmacy、Scounding Pharmacy0、Bounding Pharmac）、Bounding PharmaVcy 或Bounding。
- 透過利用本報告中提出的見解，各公司的行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
- 全球藥房市場涉及業內各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以透過利用全球醫藥市場分析中使用的各種策略矩陣，更輕鬆地做出決策。
目錄
第1章：研究目標與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章：市場動態、監管與趨勢分析
- 市場動態
- 促進因素
- 抑制因子
- 機會
- 影響分析
- 市場趨勢
- 主要進展
- 監管趨勢
- 收購與合作趨勢
- 資金籌措及投資
- PEST分析
- 波特的分析
第4章 全球藥局市場：依產品類型分類，2021-2033年
- 概述
- 口服
- 外用
- 直腸
- 鼻內
- 眼科
第5章 全球藥局市場：依治療領域分類，2021-2033年
- 概述
- 荷爾蒙補充療法
- 疼痛管理
- 特種藥品
- 營養補充品
- 其他
第6章 全球藥局市場：依應用領域分類，2021-2033年
- 概述
- 兒童
- 成人
- 老年人
- 獸醫學
第7章 全球藥局市場：依地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
- 中東
- GCC
- 以色列
- 其他中東國家
- 非洲
- 北非
- 中非
- 南非
第8章 競爭情勢
- 公司簡介
- Avella Specialty Pharmacy
- Central Admixture Pharmacy Services
- Fagron
- Fresenius Kabi AG
- PharMEDium Services
- Institutional Pharmacy Solutions
- Cantrell Drug Company
- Triangle Compounding Pharmacies
- Lorraine's Pharmacy
- Rx3 Compounding Pharmacy
- B Braun SE
- Clinigen Group PLC
- QuVa Pharma
- ITC Compounding Pharmacy
- Advanced Pharmacy
- Myonex
第9章 分析師建議
- 機會分析
- 分析師意見
- Coherent Opportunity Map
第10章 參考文獻與調查方法
- 參考
- 調查方法
簡介目錄
Product Code: CMI3199
Compounding Pharmacies Market is estimated to be valued at USD 12.66 Bn in 2026 and is expected to reach USD 19.68 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 12.66 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.50% | 2033 Value Projection: | USD 19.68 Bn |
Global compounding pharmacies market is expected to witness growth exponentially over the forecast period, owing to rising demand for personalized medications for complex conditions. Compounding pharmacies combine or alter ingredients into customized formulations as per patient's specific clinical needs when an U.S. Food and Drug Administration approved prescription product is not available. These help to cater accurate dosing requirements and particular formulations like medications for pediatric or geriatric patients who cannot swallow solid pills. Moreover, the ability of compounders to produce medications with unique flavors and routes of administration expands treatment options. Growing geriatric population diagnosed with chronic health conditions boosts demand for compounded medications.
Market Dynamics
Global compounding pharmacies market is witnessing robust growth due to increasing incidence of chronic medical conditions worldwide requiring customized medications. Moreover, growing geriatric population base that often need specialized formulations and dose forms of drugs can drive the market growth The advantages of compounding pharmacies over commercially available drugs including unique dosage forms, pediatric dose forms, and ability to cater to patient-specific needs can also drive the market growth. However, strict regulatory framework and quality standards for compounded drugs can hamper the market growth. The availability of expensive commercial equivalents can also hamper the market growth. Increasing healthcare expenditure in emerging nations and utilization of advanced technologies in compounding can offer lucrative opportunities for the market growth.
Key Features of the Study
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global compounding pharmacies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this includes Avella Specialty Pharmacy, Central Admixture Pharmacy Services, Fagron, Fresenius Kabi AG, PharMEDium Services, Institutional Pharmacy Solutions, Cantrell Drug Company, Triangle Compounding Pharmacies, Lorraine's Pharmacy, Rx3 Compounding Pharmacy, B Braun SE, Clinigen Group PLC, QuVa Pharma, ITC Compounding Pharmacy, Advanced Pharmacy.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global compounding pharmacies market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global compounding pharmacies market.
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Oral
- Capsule
- Tablets
- Mixtures
- Lollipops
- Lozenges
- Topical
- Gels
- Ointments
- Cream
- Lotions
- Rectal
- Nasal
- Ophthalmic
- Therapeutic Area Insights (Revenue, USD Bn, 2021 - 2033)
- Hormone Replacement Therapy
- Pain Management
- Specialty Drugs
- Nutritional Supplements
- Others
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Pediatric
- Adults
- Geriatrics
- Veterinary
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Avella Specialty Pharmacy
- Central Admixture Pharmacy Services
- Fagron
- Fresenius Kabi AG
- PharMEDium Services
- Institutional Pharmacy Solutions
- Cantrell Drug Company
- Triangle Compounding Pharmacies
- Lorraine's Pharmacy
- Rx3 Compounding Pharmacy
- B Braun SE
- Clinigen Group PLC
- QuVa Pharma
- ITC Compounding Pharmacy
- Advanced Pharmacy
- Myonex
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Therapeutic Area
- Market Snapshot, By Application
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Compounding Pharmacies Market, By Product Type, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Capsule
- Tablets
- Mixtures
- Lollipops
- Lozenges
- Topical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Gels
- Ointments
- Cream
- Lotions
- Rectal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Nasal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ophthalmic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Compounding Pharmacies Market, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hormone Replacement Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Pain Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Specialty Drugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Nutritional Supplements
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Compounding Pharmacies Market, By Application, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Pediatric
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Adults
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Geriatrics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Veterinary
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Compounding Pharmacies Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Avella Specialty Pharmacy
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Central Admixture Pharmacy Services
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Fagron
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Fresenius Kabi AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- PharMEDium Services
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Institutional Pharmacy Solutions
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cantrell Drug Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Triangle Compounding Pharmacies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lorraine's Pharmacy
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Rx3 Compounding Pharmacy
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- B Braun SE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Clinigen Group PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- QuVa Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ITC Compounding Pharmacy
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Advanced Pharmacy
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Myonex
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Avella Specialty Pharmacy
9. Analyst Recommendation
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact
